LifeMD Announces Key Appointments to Drive the Launch of


NEW YORK, January 04, 2022 (GLOBE NEWSWIRE) – LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the appointments of Dennis Wijnker as Chief Technology Officer and Garett Hunter as Senior Vice President and General Manager of LifeMD Primary Care. Wijnker succeeds Stefan Galluppi, who will retain his role as Director of Innovation and Marketing for LifeMD.

Wijnker brings over 20 years of experience in software development, having held technical and managerial leadership positions. He has extensive experience building web and standalone platforms, primarily in the healthcare and life sciences fields. He joins LifeMD after working at Doctor Evidence, where he worked as a Senior Architect and Senior Vice President of Technology with various teams to create innovative solutions bringing AI-powered analytics and insights to the field of evidence-based medicine. He has also held leadership positions at Parexel / Perceptive Informatics (now Calyx), where, along with others, he developed a fully configurable web-based electronic data capture platform for clinical trial management that have been widely adopted in the industry. He was also instrumental in the introduction and implementation of clinical data standards to connect said platform to other technologies used in clinical trials.

Hunter is a proven marketer with over 15 years of experience in acquiring customers through strategic and integrated marketing campaigns. Garett joins LifeMD after Yumi, where he worked as vice president of growth. Prior to Yumi, Garett co-founded Vegamour and Gravity Brands, the former a direct-to-consumer vegan beauty brand and the latter an e-commerce company with over 2 million customers.

“We are delighted to have Dennis and Garett with us as we advance our mission of providing a caring, personalized healthcare experience that offers patients a full, one-on-one relationship with a primary care physician. Their expertise is greatly appreciated as we enter a milestone for LifeMD, with the next full launch of our virtual care platform, ”said Stefan Galluppi, Director of Innovation and Marketing for LifeMD. “We are excited to see how much we can accomplish as we continue to mature and evolve as a leading provider of telehealth. “

In accordance with Nasdaq listing rule 5635 (c) (4), the compensation committee of the board of directors of the company awarded stock awards to Wijnker and Hunter with award dates of December 29, 2021 and January 3, 2022, respectively, as stock incentive awards. outside of the company’s 2020 equity and incentive plan (but under the terms of the 2020 equity and incentive plan) and important for the acceptance of employment by employees in the company.

Wijnker has received options to purchase a total of 80,000 common shares of LifeMD, Inc. The options have an exercise price of $ 3.78, which corresponds to the closing price of the common shares of LifeMD on December 29, 2021 , date of allocation of the award. The options, which have a term of five years, will vest annually over a period of three years beginning on the date of grant, subject to the employee continuing to work for Life® on those vesting dates.

Hunter has received options to purchase a total of 50,000 common shares of LifeMD, Inc. The options have an exercise price of $ 4.12, which corresponds to the closing price of the common shares of LifeMD on January 3, 2022. , the date of allocation of the allocation. The options, which have a term of five years, will vest annually over a period of three years beginning on the date of grant, subject to the employee continuing to work for Life® on those vesting dates. On the same grant date, Hunter also received an option to purchase performance shares, with a term of four years, to purchase up to 150,000 common shares of LifeMD, Inc., subject to, among others, the brands that the employee manages to achieve certain revenue and profitability targets, as further defined in the employment contract.

About LifeMD
LifeMD, Inc. is a rapidly growing direct-to-patient telehealth company providing virtual medical care for a fee in all 50 states. LifeMD’s telemedicine platform enables virtual access to affordable and convenient medical treatment from approved providers and, where available, prescription drugs and over-the-counter products delivered directly to the patient’s home. To learn more, visit

Caution regarding forward-looking statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release may be identified by the use of words such as: “believe”, “expect”, “anticipate” “,” Plan, “” should “,” plan “,” will “,” may “,” intend “,” estimate “,” plan “,” continue “and” potential “or, in each case, their negative or other variations or comparable terminology referring to future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial prospects and directions, short and long term performance and business operations , future revenues and profits, regulatory developments, legal events or results, the ability to comply with and changing regulations, market conditions and trends, new or expanded products and offerings, l growth strategies, the underlying assumptions and the effects of all of the above on our future results of operations or financial condition.

Forward-looking statements are not historical facts and are not guarantees of future performance. Rather, these statements are based on our current expectations, beliefs and assumptions regarding future plans and strategies, projections, anticipated and unforeseen events and trends, the economy and other future conditions, including the impact of any of the aforementioned elements on our future activities. . Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances and assumptions that are difficult to predict, some of which are beyond our control. Therefore, our actual results, performance and financial condition may differ materially from those shown in forward-looking statements. These risks and uncertainties include, but are not limited to, “risk factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to our latest annual report filed on Form 10- K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even though our actual results, performance or financial condition is consistent with the forward-looking statements contained in these documents, they may not be indicative of our actual results, performance or financial condition for subsequent periods.

Any forward-looking statements made in the press release are based on information currently available to us on the date this press release is issued. We assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law or regulation.

Company contact
LifeMD, Inc.
Marc Benathen, Chief Financial Officer
Email contact

Investor Relations Contact
Ashley robinson
LifeSci Advisors, LLC
[email protected]

Contact LifeMD Virtual Primary Care Partnership
LifeMD, Inc.
Corey Deutsch, CBO
[email protected]

Eric Herman
[email protected]

Source link


Comments are closed.